Have a personal or library account? Click to login

Novel Ret Mutations in Macedonian Patients with Medullary Thyroid Carcinoma: Genotype-Phenotype Correlations/ Нови Ret-Мутации Кај Македонски Пациенти Со Медуларен Карцином На Тироидната Жлезда: Генотипско-Фенотипски Корелации

PRILOZI
Volume 36 (2015): Issue 1 (May 2015)
By:
Open Access
|Jun 2015

References

  1. 1. Jandrichova S, Vcelak J, Vlcek P, Neradilova M, Nemec J, Bendlova B. Screening of six risk exons of the ret proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. Journal of Endocrinology. 2004; 183: 257-265.10.1677/joe.1.05838
    Search in Google Scholar
  2. 2. National Cancer Institute. MedullaryThyroid Cancer. available at: http://www.cancer.gov/cancertopics/pdq/genetics/medullarythyroid/HealthProfessional/page2/print
    Search in Google Scholar
  3. 3. Eng Charis. Ret proto-oncogene in the development of human cancer. J Clin Oncol. 1999; 17(1): 380-393.10.1200/JCO.1999.17.1.380
    Search in Google Scholar
  4. 4. Maitra A, Abbas A. K. The endocrine system. In: Robbins and Cotran Pathologic basis of Disease. 7th edition, Philadelphia (Pennsylvania): Elsevier Saunders; 2005. 1155-1226.
    Search in Google Scholar
  5. 5. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gangel R. F, et al. The relationship between specific ret proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996; 276: 1575-1579.10.1001/jama.1996.03540190047028
    Search in Google Scholar
  6. 6. Matias-Guiu X, DeLellis R, Moley J. F, Gagel R. F, Slbores-Saavedra J, Bussolati G. et al. Medullary thyroid carcinoma. In: Pathology and genetics of tumors of endocrine system. World Health Organization Classification of Tumors, IARC, Lyon: IARC Press. 2001; 86-91.
    Search in Google Scholar
  7. 7. Cobanoglu B, Ozercan M.R. Staining characteristics of BCL-2, BAX, p53, p21, Ki-67 andC-erbB2 in thyroid carcinomas. Erciyes Medical Journal 2007; 29 (3): 201-209.
    Search in Google Scholar
  8. 8. Viale G, Roncalli M, Grimelius L, Graziani D, Wilander E, Johansson H, et al.: Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol. 1995; 26(9): 945-50.10.1016/0046-8177(95)90082-9
    Search in Google Scholar
  9. 9. Gerasimovski D. Census of population, households and dwellings in the Republic of Macedonia, 2002 Final data. Republic of Macedonia State Statistical Office. Book X. 2002; 10: 18-197.
    Search in Google Scholar
  10. 10. Mograbi B, Bocciardi R, Bourget I, Juhel T, Farahi- Far D, Romeo G, et al. The sensitivity of activated Cys Ret mutants to glial cell line-derived neuritrophic factor is mandatory to rescue neuroectodermal cells from apoptosis. Mol Cell Biol. 2001; 21(20): 6719-6730.10.1128/MCB.21.20.6719-6730.20019985011564857
    Search in Google Scholar
  11. 11. Komminoth P. The role of ret proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN2) gene carriers and the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Verh Dtsch Ges Pathol. 1995; 79: 50-55.
    Search in Google Scholar
  12. 12. Quayle F. J, Fialkowski E. A, Benveniste R, Moley J. F. Pheochromocytoma penetrance varies by Ret mutation in MEN2A. Surgery. 2007; 142(6): 800-805.10.1016/j.surg.2007.09.01318063059
    Search in Google Scholar
  13. 13. Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Myiauchi A, et al. Mutational analysis of the ret proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet.1998; 43(2): 101-106.10.1007/s1003800500489621513
    Search in Google Scholar
  14. 14. Linwah Y, Cote G.. J, Shapiro S. E, Ayers G. D, Herzog C. E, Sellin R. V, et al. Multiple endocrine neoplasia type 2. Evaluation of genotype-phenotype relationship. Arch Surg. 2003; 138: 409-416.10.1001/archsurg.138.4.40912686527
    Search in Google Scholar
  15. 15. Arighi E, Popsueva A, Degl’Innocenti D, Borrello M. G, Carniti C, Perala N. M, et al. Biological effects of dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschprung’s disease. Mol Endocrinol. 2004; 18(4): 1004-1017.10.1210/me.2003-017314715928
    Search in Google Scholar
  16. 16. Skinner M. A, Safford S. D, Reeves J. G, Jackson M. E, Freemerman A. J. Renal aplasia in humans is associated with Ret mutations. Am J Hum Genet. 2008; 82(2): 344-51.10.1016/j.ajhg.2007.10.008242729318252215
    Search in Google Scholar
  17. 17. Sanjay J, Encinas M, Johnson E. M Jr, Milbrandt J. Critical and distinct roles for key Ret tyrosine docking sites in renal development. Genes & Development. 2006; 20: 321-333.10.1101/gad.1387206136170316452504
    Search in Google Scholar
  18. 18. Yu O. H, Murawski I. J, Myburgh D. B, Gupta I. R. Overexpression of Ret leads to vesicoureteric reflux in mice. Am J Physiol Renal Physiol. 2004; 287: 1123-1130.10.1152/ajprenal.00444.200315328070
    Search in Google Scholar
  19. 19. Yang Y, Houle A-M, Letendre J, Richter A. Ret Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec. Human Mutation. 2008; 29(5): 695-702.10.1002/humu.2070518273880
    Search in Google Scholar
  20. 20. Ensembl. Human gene view. available at: http://www.ensembl.org/Homo_sapiens/geneview?gene=OTTHUMG00000018024;db=vega
    Search in Google Scholar
  21. 21. Gene Cards. RET gene card. available at: http://www.genecards.org/cgi-bin/carddisp.pl?gene=RET
    Search in Google Scholar
  22. 22. Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grusendorf M, et al. A new hot spot for mutations in the ret proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab. 1998; 83(3): 770-774.
    Search in Google Scholar
  23. 23. Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, et al. Ret mutations in exons 13 and 14 of FMTC patients. Oncogene. 1995; 10: 2415-2419.
    Search in Google Scholar
  24. 24. Eng C, Mulligan L. M, Smith D. P, Healey C. S, Frilling A, Raue F, et al. Mutation of the ret protooncogene in sporadic medullary thyroid carcinoma. Genes, Chromosomes and Cancer. 1995; 12: 209-212.10.1002/gcc.28701203087536460
    Search in Google Scholar
  25. 25. Fattoruso O, Quadro L, Libroia A, Verga U, Lupoli G, Cascone E, et al. A GTG to ATG novel point mutation at codon 804 in exon 14 of the ret protooncogene in two families affected by familial medullary thyroid carcinoma. Human Mutation. 1998; 1: 167-171.10.1002/humu.13801101569452077
    Search in Google Scholar
  26. 26. Da Silva A. M, Maciel R. M, Da Silva M. R, Toledo S. R, De Carvalho M. B, Cerutti J. M. A novel germline point mutation in ret exon 8 (Gly533Cys) in large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 2003; 88: 5438-5443.10.1210/jc.2003-03099714602786
    Search in Google Scholar
  27. 27. Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab. 2008; 93(3): 682-687.10.1210/jc.2007-171418073307
    Search in Google Scholar
  28. 28. Eng C, Smith D. P, Mulligan L. M, Nagai M. A, Healey C. S, Ponder M. A et al. Point mutation within the thyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet. 2003; 3(2): 237-241.10.1093/hmg/3.2.2377911697
    Search in Google Scholar
  29. 29. Hofstra R. M, Landsvater R. M, Ceccherini I, Stulp R. P, Stelwagen T, Luo Y, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 1994; 367(6461): 375-376.10.1038/367375a07906866
    Search in Google Scholar
  30. 30. Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, et al. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin endocrinol Metab. 2007; 92(12): 4725-9.10.1210/jc.2007-100517895320
    Search in Google Scholar
  31. 31. Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F et al. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab. 1996; 81(4): 1619-22.
    Search in Google Scholar
  32. 32. Zedenius J, Wallin G, Hamberger B, Nordenskjold M, Weber G, Larsson C. Hum mol Genet. 1994; 3(8): 1259-62.
    Search in Google Scholar
  33. 33. Eng C, Mulligan L. M, Smith D. P, Healey C. S, Frilling A, Raue F, et al. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.Clin Endocrinol (Oxf). 1995; 43(1): 123-7.10.1111/j.1365-2265.1995.tb01903.x
    Search in Google Scholar
  34. 34. Blaugrund J. E, Johns M. M Jr, Eby Y. J, Ball D. W, Baylin S. B, Hruban R. H, Sidransky D. Hum Mol Genet. 1994; 3(10): 1895-7.
    Search in Google Scholar
  35. 35. Machens A, Dralle H. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg. 2007; 31(5): 957-68.10.1007/s00268-006-0769-y
    Search in Google Scholar
  36. 36. Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F, the German MEN2 Study Group. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin endocrinol (Oxf). 2008; Epub ahead of print. PMID 18248648.10.1111/j.1365-2265.2008.03215.x
    Search in Google Scholar
  37. 37. Elisei R, Cosici B, Romei C, Agate L, Piampiani P, Miccoli P, et al. Identification of novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. J Clin Endocrinol Metab. 2004; 89(11): 5823-7.10.1210/jc.2004-0312
    Search in Google Scholar
  38. 38. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. USA. 1989; 86: 2766-2770.10.1073/pnas.86.8.2766
    Search in Google Scholar
  39. 39. Glavac D, Dean M. Optimization of the singlestrand conformation polymorphism (SSCP) technique for detection of point mutations. Hum Mutat. 1993; 2(5): 404-414.10.1002/humu.1380020513
    Search in Google Scholar
  40. 40. Kumar P, Henikoff S, Ng P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009; 4(7): 1073-1081.10.1038/nprot.2009.86
    Search in Google Scholar
  41. 41. Choi Y, Sims G. E, Murphy S, Miller J. R, Chan A. P (2012) Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLoS ONE 7(10): e46688. Available at: http://provean.jcvi.org/index.php10.1371/journal.pone.0046688
    Search in Google Scholar
  42. 42. StatSoft, Inc. (2001). STATISTICA (data analysis software system), version 6. www.statsoft.com.
    Search in Google Scholar
  43. 43. Desmet F. O, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acid Research, 2009. available at: http://www.umd.be/HSF/10.1093/nar/gkp215
    Search in Google Scholar
  44. 44. Schilling T, Burck J, Sinn H. P, Clemens A, Otto H. F, Hoppner W, et al. Prognostic value of codon 918(ATG>ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer. 2001; 95(1): 62-6.10.1002/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1
    Search in Google Scholar
  45. 45. Leboulleux S, Baudin E, Travagli J. P, Schlumberger M. Medullary thyroid carcinoma. Clinical Endocrinology. 2004; 61: 299-310. doi: 10.1111/j.1365-2265.2004.02037.x 10.1111/j.1365-2265.2004.02037.x15355445
    Search in Google Scholar
DOI: https://doi.org/10.1515/prilozi-2015-0034 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 93 - 107
Published on: Jun 16, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
RET mutations,
Medullary thyroid carcinoma,
Ki-67,
Bcl-2.
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2015 Rubens Jovanovic, Slavica Kostadinova-Kunovska, Vesna Janevska, Biljana Bogoeva, Liljana Spasevska, Daniela Miladinova, Ana Ugrinska, Marina Zdraveska-Kochovska, Dejan Trajkov, Gordana Petrusevska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 36 (2015): Issue 1 (May 2015)Next article